Ekaterini Antoniadou-Vyza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ekaterini Antoniadou-Vyza has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Afrodite Voulgari
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Athens, Greece
3 shared publicationsDimitra Benaki
Institute of Biology, NCSR “Demokritos” Aghia Paraskevi, Athens, Greece
3 shared publicationsSotiris Michaleas
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Athens, Greece
3 shared publicationsStavroula Rozou
R&D Department, ELPEN Pharmaceutical Company, Attica, Greece
3 shared publicationsE. Lada‐Chitiroglou
Department of Microbiology, School of Medicine, University of Athens , Goudi, Athens 11527
1 shared publicationEvangelos Ch. Kotzagiorgis
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece
1 shared publication
Latest Publications
- 12 October 2009
- Published by Wiley in Journal of Separation Science
- Vol. 32 (20) , 3521-3528
New SPE loading material for affinity‐based separation of cyclodextrins from drug:CD complexes in order to overcome Beer's law deviations
Molecular inclusion of guest molecules within CDs is known to alter guest molecule spectrophotometric absorptivity, making their determination, based on spectrophotometric data, inaccurate. Therefore specific analytical methods capable of quantifying the drugs as free molecules must be developed and validated. SPE was selected to simplify sample and avoid more time‐consuming alternatives. A new solid phase was synthesized and characterized by infrared spectrometry, differential scanning calorimetry and elemental analysis. The competitive complexation of adamantane groups immobilized on the silica substrate facilitates drug:CD complex dissociation and elimination of CD from samples. The drug molecules, now free from CD, can be easily analysed by an already available HPLC method. This new SPE loading material was employed in the determination of ketoprofen in its CD complex as a representative example of the utility of this novel material. The calculated analytical errors were reduced from a maximum of 20.79% (without SPE) to a minimum of 3.99%.
- 12 October 2009
- Published by Wiley in Journal of Separation Science
- Vol. 32 (20) , 3521-3528
New SPE loading material for affinity‐based separation of cyclodextrins from drug:CD complexes in order to overcome Beer's law deviations
Molecular inclusion of guest molecules within CDs is known to alter guest molecule spectrophotometric absorptivity, making their determination, based on spectrophotometric data, inaccurate. Therefore specific analytical methods capable of quantifying the drugs as free molecules must be developed and validated. SPE was selected to simplify sample and avoid more time‐consuming alternatives. A new solid phase was synthesized and characterized by infrared spectrometry, differential scanning calorimetry and elemental analysis. The competitive complexation of adamantane groups immobilized on the silica substrate facilitates drug:CD complex dissociation and elimination of CD from samples. The drug molecules, now free from CD, can be easily analysed by an already available HPLC method. This new SPE loading material was employed in the determination of ketoprofen in its CD complex as a representative example of the utility of this novel material. The calculated analytical errors were reduced from a maximum of 20.79% (without SPE) to a minimum of 3.99%.
- 24 March 2009
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 64 (3-4) , 289-297
Photostabilization of oxolinic acid in hydroxypropyl-β-cyclodextrins; implications for the effect of molecular self-assembly phenomena
- 24 March 2009
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 64 (3-4) , 289-297
Photostabilization of oxolinic acid in hydroxypropyl-β-cyclodextrins; implications for the effect of molecular self-assembly phenomena
- 12 March 2007
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (4) , 1370-1375
Improved photostability indicating ion-pair chromatography method for pergolide analysis in tablets and in the presence of cyclodextrins
- 12 March 2007
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (4) , 1370-1375
Improved photostability indicating ion-pair chromatography method for pergolide analysis in tablets and in the presence of cyclodextrins
- 18 January 2007
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 57 (1-4) , 141-146
The effect of β-cyclodextrin on tenoxicam photostability, studied by a new liquid chromatography method; the dependence on drug dimerisation
- 18 January 2007
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 57 (1-4) , 141-146
The effect of β-cyclodextrin on tenoxicam photostability, studied by a new liquid chromatography method; the dependence on drug dimerisation
- 2 July 2004
- Published by Elsevier in Journal of Chromatography A
- Vol. 1041 (1-2) , 187-194
Chromatographic behaviour of naproxen–cyclodextrin complexes: Stationary phase C8 alkyl chain as competitor for the drug release from cyclodextrin cavity
- 2 July 2004
- Published by Elsevier in Journal of Chromatography A
- Vol. 1041 (1-2) , 187-194
Chromatographic behaviour of naproxen–cyclodextrin complexes: Stationary phase C8 alkyl chain as competitor for the drug release from cyclodextrin cavity
- 1 March 2003
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (3) , 291-300
Antimicrobial activity of β-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance
Recognition and uptake by specific cellular receptors and transport systems for cyclodextrins have been demonstrated. Based on this concept, natural and synthetically modified cyclodextrins were used as drug carriers. Several β-lactam antibiotics were selected and their inclusion complexes with different cyclodextrins were prepared (molar ratio ranging from 1:1 to 1:3). The complex formation, in aqueous solution, was monitored and optimum complexation conditions were selected. The inclusion of the active molecules in the cyclodextrin cavity was confirmed by 1H NMR spectroscopy. Specific HPLC methods for the quantitation of antibiotics in the presence of cyclodextrins were developed and their chemical stability under complexation conditions was confirmed. Antimicrobial activity of drug-cyclodextrin complexes, in terms of minimum inhibitory concentration (MIC), were compared with the corresponding values of uncomplexed free molecules. A wide range of clinical pathogens and known β-lactamase-producing strains were tested. The activity of the cyclodextrin-included antibiotics was increased, particularly against Gram-negative clinical strains. The nature and degree of substitution on cyclodextrin macromolecules may be the predominant factor in the observed improvement in antimicrobial activity. We believe that the proposed methodology is a novel approach to the microbial resistance problem and will trigger research towards the development of new cyclodextrin derivatives bearing the ability to increase the uptake of included antimicrobial molecules through intensification of the corresponding molecular recognition phenomena.
- 1 March 2003
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (3) , 291-300
Antimicrobial activity of β-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance
Recognition and uptake by specific cellular receptors and transport systems for cyclodextrins have been demonstrated. Based on this concept, natural and synthetically modified cyclodextrins were used as drug carriers. Several β-lactam antibiotics were selected and their inclusion complexes with different cyclodextrins were prepared (molar ratio ranging from 1:1 to 1:3). The complex formation, in aqueous solution, was monitored and optimum complexation conditions were selected. The inclusion of the active molecules in the cyclodextrin cavity was confirmed by 1H NMR spectroscopy. Specific HPLC methods for the quantitation of antibiotics in the presence of cyclodextrins were developed and their chemical stability under complexation conditions was confirmed. Antimicrobial activity of drug-cyclodextrin complexes, in terms of minimum inhibitory concentration (MIC), were compared with the corresponding values of uncomplexed free molecules. A wide range of clinical pathogens and known β-lactamase-producing strains were tested. The activity of the cyclodextrin-included antibiotics was increased, particularly against Gram-negative clinical strains. The nature and degree of substitution on cyclodextrin macromolecules may be the predominant factor in the observed improvement in antimicrobial activity. We believe that the proposed methodology is a novel approach to the microbial resistance problem and will trigger research towards the development of new cyclodextrin derivatives bearing the ability to increase the uptake of included antimicrobial molecules through intensification of the corresponding molecular recognition phenomena.